- 関
- cytomegalovirus immune globulin
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Cytomegalovirus in pediatric systemic lupus erythematosus: prevalence and clinical manifestations.
- Rozenblyum EV1, Levy DM2, Allen U3, Harvey E4, Hebert D4, Silverman ED2.
- Lupus.Lupus.2015 Jun;24(7):730-5. doi: 10.1177/0961203314565443. Epub 2015 Jan 6.
- Cytomegalovirus (CMV) is a beta-herpesvirus and antibodies to this virus are common in patients with systemic lupus erythematosus (SLE). However, few studies have examined the relationship between CMV infection and SLE.OBJECTIVES: Our objectives were: 1) to determine the prevalence of CMV infection
- PMID 25568145
- In vitro evaluation of cytomegalovirus-specific hyperimmune globulins vs. standard intravenous immunoglobulins.
- Miescher SM1, Huber TM, Kühne M, Lieby P, Snydman DR, Vensak JL, Berger M.
- Vox sanguinis.Vox Sang.2015 Mar 12. doi: 10.1111/vox.12246. [Epub ahead of print]
- BACKGROUND AND OBJECTIVES: To evaluate standard intravenous immunoglobulin (IVIG) as an alternative to intravenous cytomegalovirus hyperimmune immunoglobulin (CMVIG) for prophylaxis and therapy of cytomegalovirus (CMV) disease, we measured the ELISA and neutralizing titres of CMV-specific antibodies
- PMID 25766313
- A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
- Revello MG1, Lazzarotto T, Guerra B, Spinillo A, Ferrazzi E, Kustermann A, Guaschino S, Vergani P, Todros T, Frusca T, Arossa A, Furione M, Rognoni V, Rizzo N, Gabrielli L, Klersy C, Gerna G; CHIP Study Group.
- The New England journal of medicine.N Engl J Med.2014 Apr 3;370(14):1316-26. doi: 10.1056/NEJMoa1310214.
- BACKGROUND: Congenital infection with human cytomegalovirus (CMV) is a major cause of morbidity and mortality. In an uncontrolled study published in 2005, administration of CMV-specific hyperimmune globulin to pregnant women with primary CMV infection significantly reduced the rate of intrauterine t
- PMID 24693891
Japanese Journal
- The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland
Related Links
- CytoGam® is indicated for the prophylaxis of cytomegalovirus (CMV) disease associated with transplantation of kidney, lung, liver, pancreas, and heart.
- CytoGam. ® contains no preservative. The purified immunoglobulin is derived from pooled adult human plasma selected for high titers of antibody for Cytomegalovirus (CMV) (1). Source material for fractionation may be obtained from another ...
Related Pictures